Published in Br J Clin Pharmacol on November 01, 1987
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
Dose-response study with high-dose inhaled salmeterol in healthy subjects. Br J Clin Pharmacol (1992) 1.33
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J (1990) 1.18
Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. Thorax (1995) 1.14
Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax (1995) 1.12
Hypokalemia and sudden cardiac death. Exp Clin Cardiol (2010) 0.98
Intravenous beta agonist in severe acute asthma. BMJ (1988) 0.94
The current debate concerning beta-agonists in asthma: a review. J R Soc Med (1993) 0.92
Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance? Br J Clin Pharmacol (1992) 0.92
Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers. Br J Clin Pharmacol (1989) 0.89
Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol (2011) 0.88
Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax (1994) 0.88
Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers. Br J Clin Pharmacol (1991) 0.87
Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers. Br J Clin Pharmacol (1990) 0.87
The myocardial effects of fenoterol, isoprenaline and salbutamol in normoxic and hypoxic sheep. Int J Exp Pathol (1994) 0.84
K2P potassium channels, mysterious and paradoxically exciting. Sci Signal (2011) 0.82
Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system. Br J Clin Pharmacol (1999) 0.79
The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise. Br J Clin Pharmacol (1993) 0.78
The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure. Br J Clin Pharmacol (1998) 0.77
Studies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma. Br J Clin Pharmacol (1993) 0.75
Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics. Ther Clin Risk Manag (2016) 0.75
Albuterol in the treatment of acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. World J Emerg Med (2015) 0.75
The action of adrenaline on serum potassium. J Physiol (1934) 10.03
Presynaptic regulation of the release of catecholamines. Pharmacol Rev (1980) 4.20
Mechanisms regulating renin release. Physiol Rev (1976) 3.08
Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. Br Med J (1976) 2.16
Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J (1983) 1.79
Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet (1976) 1.77
Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55
Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy (1985) 1.46
Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. Br Med J (1977) 1.32
Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism (1980) 1.28
The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist. Clin Pharmacol Ther (1986) 1.23
Metabolic responses to beta 2 stimulants. J R Coll Physicians Lond (1984) 1.17
Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet (1983) 1.14
Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest (1980) 1.10
Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. J Cardiovasc Pharmacol (1984) 1.06
Hypokalaemia induced by inhalation of fenoterol. Lancet (1985) 1.02
Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in man. Br J Clin Pharmacol (1982) 0.97
Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand Suppl (1983) 0.96
The role of insulin in beta 2-receptor mediated hypokalemia. Clin Endocrinol (Oxf) (1985) 0.91
Plasma norepinephrine in the evaluation of baroreceptor function in humans. Hypertension (1983) 0.88
A comparison of the duration of action of fenoterol and salbutamol in asthma. Curr Med Res Opin (1981) 0.87
The renin-angiotensin-aldosterone system, antidiuretic hormone levels and water balance under tocolytic therapy with Fenoterol and Verapamil. Int J Gynaecol Obstet (1980) 0.86
Adrenaline causes hypokalaemia in man by beta 2 adrenoceptor stimulation. Clin Endocrinol (Oxf) (1984) 0.85
Effect of salbutamol inhalations of plasma and urinary cyclic adenosine monophosphate levels in asthmatics and non-atopic controls. Scand J Respir Dis (1976) 0.83
Parenteral adrenergic bronchodilators and potassium. Chest (1986) 0.81
Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects. Br J Clin Pharmacol (1984) 0.81
Effects of beta-adrenergic agents on hypokalemia. Chest (1987) 0.80
The proper use of metered dose inhalers. Chest (1984) 0.79
Efficacy of parenteral albuterol in the treatment of asthma. Comparison of its metabolic side effects with subcutaneous epinephrine. Chest (1986) 0.79
[Modification of plasma cAMP using inhalation and parenteral beta 2-adrenergic stimulators]. Pneumonologie (1976) 0.79
Drug level monitoring of antiasthmatic drugs. J Chromatogr (1985) 0.78
Midazolam kinetics. Clin Pharmacol Ther (1981) 2.88
Anterior colporrhaphy compared with collagen-coated transvaginal mesh for anterior vaginal wall prolapse: a randomised controlled trial. BJOG (2013) 2.03
Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther (1989) 1.73
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol (1991) 1.67
Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens (2000) 1.53
A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference. Int J Obes Relat Metab Disord (2002) 1.21
Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med (1998) 1.20
Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry (1999) 1.15
Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.14
Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Contraception (1987) 1.04
An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol (2001) 1.04
Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats. Br J Pharmacol (1995) 1.02
Inverse correlation between serum testosterone and leptin in men. J Clin Endocrinol Metab (1998) 1.01
Effect of food on the bioavailability of labetalol. Br J Clin Pharmacol (1980) 1.00
Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J (2001) 1.00
Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis (2001) 0.99
Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device. Contraception (1990) 0.96
Identification of new sequence variants in the leptin gene. J Clin Endocrinol Metab (1998) 0.96
Saliva concentrations of lignocaine in healthy volunteers. Br J Clin Pharmacol (1982) 0.95
Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab (1999) 0.95
Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res (2000) 0.94
Pooling analysis of genetic data: the association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity. Genetics (2001) 0.93
Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes. Exp Clin Endocrinol Diabetes (2000) 0.92
Sudden deafness: a comparison of anticoagulant therapy and carbogen inhalation therapy. Ann Otol Rhinol Laryngol (1997) 0.90
Hepatic metabolism and distribution of mifepristone and its metabolites in rats. Hum Reprod (1994) 0.90
Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers. Br J Clin Pharmacol (1987) 0.90
Effect of hypothermia on blood-flow responses in pedicled groin flaps in rats. Br J Plast Surg (2002) 0.90
Five years' experience with levonorgestrel-releasing IUDs. Contraception (1986) 0.90
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline. Clin Neuropharmacol (1996) 0.89
Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. J Clin Endocrinol Metab (2000) 0.87
Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y. Eur J Pharmacol (1995) 0.86
Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity. Eur J Pharmacol (1986) 0.85
CYP2A6 genotype and smoking. Mol Psychiatry (2000) 0.85
Stimulatory effect of acute baclofen administration on human growth hormone secretion. J Clin Endocrinol Metab (1979) 0.85
Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior. Am J Med Genet (2000) 0.85
Association between increased serotonin metabolism in rat brainstem nuclei and development of spontaneous hypertension. Brain Res (1986) 0.85
Determination of conjugated dopamine in cerebrospinal fluid from humans and non-human primates with high performance liquid chromatography using electrochemical detection. Acta Pharmacol Toxicol (Copenh) (1984) 0.84
Radiological parameters of the bony nasopharynx and the adenotonsillar size compared with sleep apnea episodes in children. Int J Pediatr Otorhinolaryngol (1987) 0.84
Oral contraceptive containing natural estradiol for premenopausal women. Maturitas (1995) 0.84
Peritonsillar abscess associated with infectious mononucleosis. ORL J Otorhinolaryngol Relat Spec (1998) 0.84
Pharmacokinetics and the sedative effect of midazolam. Int J Clin Pharmacol Ther Toxicol (1983) 0.83
Second-trimester abortion caused by Capnocytophaga sputigena: case report. Am J Perinatol (1999) 0.83
Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. J Clin Endocrinol Metab (2000) 0.83
Diabetes-induced alteration in brain monoamine metabolism in rats. J Pharmacol Exp Ther (1986) 0.83
Correlation between circulating leptin and luteinizing hormone during the menstrual cycle in normal-weight women. Eur J Endocrinol (1998) 0.83
Neuropeptide Y: a novel link between the neuroendocrine system and cholesterol metabolism. Ann Med (1998) 0.82
The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy. Exp Clin Endocrinol Diabetes (2006) 0.82
Pharmacokinetics of labetalol in healthy volunteers. Int J Clin Pharmacol Ther Toxicol (1981) 0.82
Intrauterine contraception with Nova-T and copper-T-200 during three years. Contraception (1981) 0.81
A follow-up study of patients suffering from sudden sensorineural hearing loss. Acta Otolaryngol (2001) 0.81
Pharmacokinetics of nitrazepam in saliva and serum after a single oral dose. Acta Pharmacol Toxicol (Copenh) (1979) 0.81
Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY. J Clin Endocrinol Metab (2001) 0.81
The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans. Int J Clin Pharmacol Ther Toxicol (1982) 0.80
Determination of metformin in plasma by high-performance liquid chromatography. J Chromatogr (1992) 0.80
Effect of melatonin on L-tryptophan- and apomorphine-stimulated growth hormone secretion in man. J Clin Endocrinol Metab (1979) 0.79
The effect of methysergide, pimozide, and sodium valproate on the diazepam-stimulated growth hormone secretion in man. J Clin Endocrinol Metab (1979) 0.79
Effects of stellate ganglion stimulation on bilateral cochlear blood flow. Ann Otol Rhinol Laryngol (1993) 0.79
Brain monoamine metabolism and rotational behaviour induced by experimental herpes simplex virus encephalitis. J Neural Transm Gen Sect (1991) 0.79
Radiotherapy enhanced ototoxicity of cisplatin in children. Acta Otolaryngol Suppl (1997) 0.79
Effect of subchronic metformin treatment on macronutrient selection in genetically obese Zucker rats. Pharmacol Toxicol (1993) 0.79
Clinical experience with intrauterine contraceptive devices (IUDs) inserted with and without tail. Acta Chir Hung (1988) 0.79
Radical meatoplasty in the treatment of severe chronic external otitis. ORL J Otorhinolaryngol Relat Spec (2001) 0.78
Changes in blood flow in the partially elevated epigastric pedicled flap in response to occlusion of the femoral artery in rats. J Reconstr Microsurg (2001) 0.78
Hydrops-induced changes in cochlear blood flow. Ann Otol Rhinol Laryngol (1995) 0.78
Hypothalamic neuropeptide expression after food restriction in Zucker rats: evidence of persistent neuropeptide Y gene activation. Brain Res Mol Brain Res (1992) 0.78
Circadian covariation of norepinephrine and serotonin in the locus coeruleus and dorsal raphe nucleus in the rat. Brain Res (1986) 0.78
Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats. Life Sci (1992) 0.78
Intrauterine contraception with levonorgestrel: a comparative randomised clinical performance study. Lancet (1981) 0.78
Acute effects of medetomidine, a selective alpha 2-adrenoceptor agonist, on anterior pituitary hormone and cortisol secretion in man. Acta Endocrinol (Copenh) (1988) 0.78
Effects of electrical stimulation of the superior cervical ganglion on cochlear blood flow in guinea pig. Acta Otolaryngol (1993) 0.78
Differential regulation of uncoupling proteins by chronic treatments with beta 3-adrenergic agonist BRL 35135 and metformin in obese fa/fa Zucker rats. Biochem Biophys Res Commun (1998) 0.78
COMT inhibition by entacapone does not affect growth hormone or prolactin secretion in healthy volunteers. J Neural Transm (Vienna) (1996) 0.78
Transtympanic versus tympanic membrane electrocochleography in examining cochleovestibular disorders. Acta Otolaryngol Suppl (2000) 0.78
A central 6-hydroxydopamine lesion prevents fluphenazine-induced increase in plasma homovanillic acid. Brain Res Bull (1988) 0.77
Effect of a single dose of TCDD on the level of histamine in discrete nuclei in rat brain. Agents Actions (1991) 0.77
Effect of chronic treatment with TFMPP, a 5-HT1 receptor agonist, on food intake, weight gain, plasma insulin and neuropeptide mRNA expression in obese Zucker rats. Eur J Pharmacol (1993) 0.77
Pharmacological effects of medetomidine in humans. Acta Vet Scand Suppl (1989) 0.77
Effect of a single lethal dose of TCDD on the levels of monoamines, their metabolites and tryptophan in discrete brain nuclei and peripheral tissues of Long-Evans rats. Pharmacol Toxicol (1993) 0.77
A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy. Acta Neurol Scand (1990) 0.77
Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers. Life Sci (1990) 0.77
Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase. Adv Pharmacol (1998) 0.77
The glucocorticoid antagonist mifepristone reveals abnormal regulation of the adrenocortical system in obese Zucker rats. J Endocrinol (1992) 0.77
Electronystagmographic findings in patients with acute cerebral vascular disease and vertigo. Acta Otolaryngol Suppl (2000) 0.77
Neuropeptide Y polymorphism and alcohol consumption in middle-aged men. Am J Med Genet (2000) 0.77
The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet. Eur J Clin Nutr (2002) 0.77
Cochleovestibular symptoms related to the site of vestibular schwannoma. Acta Otolaryngol Suppl (2000) 0.77
Substance P increases cochlear blood flow without changing cochlear electrophysiology in rats. Hear Res (1993) 0.77
Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance. Eur J Pharmacol (1998) 0.76
Chronic treatment with BRL 35135 potentiates the action of insulin on lipid metabolism. Eur J Pharmacol (1997) 0.76
Diabetes-induced changes in monoamine concentrations of rat hypothalamic nuclei. Brain Res (1987) 0.76
Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity. Eur J Pharmacol (1997) 0.76
Pharmacokinetics of dihydroergotamine in healthy volunteers and in neurological patients after a single intravenous injection. Int J Clin Pharmacol Ther Toxicol (1981) 0.76
Adrenal catecholamine metabolism and myocardial adrenergic receptors in streptozotocin diabetic rats. Biochem Pharmacol (1987) 0.76
The effect of metoclopramide and propantheline on the gastrointestinal absorption of cimetidine. Br J Clin Pharmacol (1981) 0.76
Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine. Int J Clin Pharmacol Biopharm (1979) 0.76
Ultrasound and antral lavage in the examination of maxillary sinuses. Rhinology (2001) 0.76
Metformin and brown adipose tissue thermogenetic activity in genetically obese Zucker rats. Eur J Pharmacol (1993) 0.76
Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise. Br J Pharmacol (1994) 0.76
The effect of promontorial bone on laser light transmission in measuring capillary blood flow in vivo. Eur Arch Otorhinolaryngol (2001) 0.76